Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07079007

Use of Water Ingestion in Small Intestine Ultrasound

Use of Water Ingestion to Improve Visualisation in Small Intestine Ultrasound (WIVIUS): Single Centre Blinded Crossover Trial

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
55 (estimated)
Sponsor
Austin Health · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Small Intestine Contrast Ultrasonography (SICUS) is an ultrasound-based method that explores bowel loops, and is able to identify wall thickness, intestinal motility, bowel wall vascularity and complications such as stenosis or dilatation. Previous studies have utilised oral ingestion of an oral contrast solution (usually PEG dissolved in a volume of water ranging from 250 to 1000mL), in order to increase the sensitivity of ultrasound, especially in stricture detection. Parameters that have been improved include lumen distension to better delineate bowel wall layers, and improved peristalsis. Diffusion of this technique has been limited, in part due to PEG-based agents being costly, time consuming and are not tolerated well in some individuals. Utilisation of water as oral contrast may improve patient tolerability and therefore increase uptake of water ingested intestinal contrast ultrasound (WICUS) as a technique in routine clinical practice. The investigators aim to study the tolerability and the improvement of image quality utilising water as an oral contrast for intestinal ultrasonography.

Conditions

Interventions

TypeNameDescription
OTHERWaterPatients that meet the inclusion and exclusion criteria would be asked to ingest 1000ml water as part of standard of care.

Timeline

Start date
2025-07-01
Primary completion
2025-11-01
Completion
2026-02-01
First posted
2025-07-22
Last updated
2025-07-22

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT07079007. Inclusion in this directory is not an endorsement.